Showing results (21-30 of 379) with videos related to
Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Activation of human T cell clones and Jurkat cells by cross-linking class I MHC moleculesT D Geppert, M C Wacholtz, S S Patel, et al.The Journal of Experimental Medicine|October 1, 1990
Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transductionH Gur, F el-Zaatari, T D Geppert, et al.The Journal of Rheumatology. Supplement|May 4, 1999
Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?P E LipskyAmerican Journal of Orthopedics (Belle Mead, N.J.)|April 8, 1999
Role of cyclooxygenase-1 and -2 in health and diseaseP E LipskyZeitschrift Fur Rheumatologie|January 1, 1988
Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritisP E LipskyThe Journal of Rheumatology. Supplement|January 1, 1981
Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell functionP E LipskyResearch in Immunology|May 1, 1990
The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells--a model of T cell/B cell collaborationP E LipskyThe Journal of Clinical Investigation|January 1, 1984
Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytesP E LipskyClinical and Experimental Rheumatology|September 1, 1989
Mechanisms of action of slow-acting drugs in rheumatoid arthritisP E LipskyPageof 38